BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37777809)

  • 1. Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy.
    Jin Y; Lan A; Dai Y; Jiang L; Liu S
    Eur J Med Res; 2023 Sep; 28(1):394. PubMed ID: 37777809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texture analysis using machine learning-based 3-T magnetic resonance imaging for predicting recurrence in breast cancer patients treated with neoadjuvant chemotherapy.
    Eun NL; Kang D; Son EJ; Youk JH; Kim JA; Gweon HM
    Eur Radiol; 2021 Sep; 31(9):6916-6928. PubMed ID: 33693994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features.
    Meti N; Saednia K; Lagree A; Tabbarah S; Mohebpour M; Kiss A; Lu FI; Slodkowska E; Gandhi S; Jerzak KJ; Fleshner L; Law E; Sadeghi-Naini A; Tran WT
    JCO Clin Cancer Inform; 2021 Jan; 5():66-80. PubMed ID: 33439725
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
    Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
    Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of machine learning model in predicting the likelihood of blood transfusion after hip fracture surgery.
    Chen X; Pan J; Li Y; Tang R
    Aging Clin Exp Res; 2023 Nov; 35(11):2643-2656. PubMed ID: 37733228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposing a novel molecular subtyping scheme for predicting distant recurrence-free survival in breast cancer post-neoadjuvant chemotherapy with close correlation to metabolism and senescence.
    Huang J; Zhang JL; Ang L; Li MC; Zhao M; Wang Y; Wu Q
    Front Endocrinol (Lausanne); 2023; 14():1265520. PubMed ID: 37900131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An MRI-based machine learning radiomics can predict short-term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study.
    Xin Z; Yan W; Feng Y; Yunzhi L; Zhang Y; Wang D; Chen W; Peng J; Guo C; Chen Z; Wang X; Zhu J; Lei J
    Cancer Med; 2023 Oct; 12(19):19383-19393. PubMed ID: 37772478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative digital histopathology and machine learning to predict pathological complete response to chemotherapy in breast cancer patients using pre-treatment tumor biopsies.
    Saednia K; Lagree A; Alera MA; Fleshner L; Shiner A; Law E; Law B; Dodington DW; Lu FI; Tran WT; Sadeghi-Naini A
    Sci Rep; 2022 Jun; 12(1):9690. PubMed ID: 35690630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
    Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
    Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of machine learning algorithm in predicting distant metastasis of T1 gastric cancer.
    Tian H; Liu Z; Liu J; Zong Z; Chen Y; Zhang Z; Li H
    Sci Rep; 2023 Apr; 13(1):5741. PubMed ID: 37029221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning is an effective method to predict the 90-day prognosis of patients with transient ischemic attack and minor stroke.
    Chen SD; You J; Yang XM; Gu HQ; Huang XY; Liu H; Feng JF; Jiang Y; Wang YJ
    BMC Med Res Methodol; 2022 Jul; 22(1):195. PubMed ID: 35842606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-year survival status prognosis of nonmetastatic cervical cancer patients through machine learning algorithms.
    Yu W; Lu Y; Shou H; Xu H; Shi L; Geng X; Song T
    Cancer Med; 2023 Mar; 12(6):6867-6876. PubMed ID: 36479910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
    Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
    Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of machine learning techniques for predicting survival in ovarian cancer.
    Sorayaie Azar A; Babaei Rikan S; Naemi A; Bagherzadeh Mohasefi J; Pirnejad H; Bagherzadeh Mohasefi M; Wiil UK
    BMC Med Inform Decis Mak; 2022 Dec; 22(1):345. PubMed ID: 36585641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic model for HER2-low breast cancer to evaluate neoadjuvant therapy.
    Li X; Lin Z; Yu Q; Qiu C; Lai C; Huang H; Zhang Y; Zhang W; Zhu J; Huang X; Li W
    Gland Surg; 2023 Feb; 12(2):183-196. PubMed ID: 36915818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Jung JJ; Kim EK; Kang E; Kim JH; Kim SH; Suh KJ; Kim SM; Jang M; Yun B; Park SY; Lim C; Han W; Shin HC
    J Breast Cancer; 2023 Aug; 26(4):353-362. PubMed ID: 37272242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer.
    Yoen H; Kim SY; Lee DW; Lee HB; Cho N
    Korean J Radiol; 2023 Jul; 24(7):626-639. PubMed ID: 37404105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.